What Are the Challenges in Post Market Surveillance for Cancer?
Post market surveillance in cancer faces several challenges:
Data Collection: Gathering comprehensive and accurate data from diverse healthcare settings can be difficult. Patient Follow-Up: Long-term follow-up is essential to understand the chronic effects of cancer treatments, but maintaining contact with patients over many years is challenging. Regulatory Hurdles: Different countries have varying regulatory requirements, complicating global surveillance efforts. Resource Allocation: Conducting thorough PMS requires significant resources, including time, money, and expertise.
